Edastuskiri
| Dokumendiregister | Terviseamet |
| Viit | 8-2/25/9818-1 |
| Registreeritud | 05.12.2025 |
| Sünkroonitud | 08.12.2025 |
| Liik | Sissetulev dokument |
| Funktsioon | 8 Nakkushaiguste seire, ennetuse ja tõrje korraldamine |
| Sari | 8-2 Nakkushaiguste epidemioloogiaalane riigiväline kirjavahetus |
| Toimik | 8-2/2025 |
| Juurdepääsupiirang | Avalik |
| Juurdepääsupiirang | |
| Adressaat | ECDC respiratory viruses |
| Saabumis/saatmisviis | ECDC respiratory viruses |
| Vastutaja | Kärt Sõber (TA, Peadirektori asetäitja (1) vastutusvaldkond, Nakkushaiguste epidemioloogia osakond) |
| Originaal | Ava uues aknas |
Failid
|
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. |
To: National Focal Points for Viral Respiratory Diseases, Operational Contact Points (Epi, Micro,TESSy) for( Influenza, Covid-19, SARI) for ERVI-Net
Observer National Focal Points for Viral Respiratory Diseases (Enlargement Countries)
Contact Points for Operations (Epi, Micro, Tessy) for ( Influenza, Covid-19, SARI) for ERVI –Net (Enlargement Countries)
Cc: National Coordinators, National Correspondents (Enlargement Countries)
Dear colleagues
We wanted to share with you the following occasions in December/January where the publication of ERVISS will deviate from the usual schedule due to office closures at ECDC and/or WHO/Euro.
|
Latest reporting week in data |
Usual publication date |
Revised publication date / notes |
|
2025-W51 |
26 December 2025 |
No ERVISS publication and no onward data submission to WHO HQ that week |
|
2025-W52 |
2 January 2025 |
Monday 5 January 2025 |
Data submission deadlines to TESSy remain the same (Wednesdays 23:59). Please note that the submission for week 2025-W52 falls on 31 January. We acknowledge that reporting may be delayed during this period; however, we still plan to publish ERVISS and will include a note in the summary to highlight the limited or/and delayed availability of data over the holiday period.
Thank you for your continued data submission and contribution to regional respiratory virus surveillance!
Best wishes
WHO/Europe and ECDC Respiratory Virus Teams
|
|||||||||||||||||||||
|
|
Confidentiality Notice
If you are not the intended recipient of this message, you are hereby kindly requested, to, consecutively, refrain from disclosing its content to any third party, delete it and inform its sender of the erroneous transmittal.
Classified as ECDC NORMAL
